Hepatology, Medicine and Policy
2059-5166
Cơ quản chủ quản: N/A
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting
- 2018
Correction to: Hepatology, Medicine and Policy: Articles with DOIs 10.1186/s41124-016-0014-8, 10.1186/s41124-016-0013-9 and 10.1186/s41124-016-0012-x
Tập 3 Số 1 - 2018
Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia
Tập 3 - Trang 1-9 - 2018
Universal access to the hepatitis C direct acting antiviral (DAAs) regimens
presents a unique opportunity to eliminate hepatitis C in Australia. Large
numbers of Australians have already been cured using these treatments, however,
the numbers presenting for treatment have begun to plateau. This study explored
how people experienced and understood being cured of hepatitis C, with the aim
of informi...
Editor-in-Chief’s welcome to Hepatology, Medicine and Policy
Tập 1 - Trang 1-3 - 2016
Hepatology, Medicine and Policy (HMAP), a new open-access peer-reviewed journal,
is making its debut at a time when the hepatitis field is seeing great progress
but still has far to go. The World Health Organization and many countries have
shown increasing interest in viral hepatitis in recent years, helping to foster
a stronger response to this group of diseases. Meanwhile, alcohol-associated
cir...
Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)
Tập 1 - Trang 1-13 - 2016
Hepatitis B and C are major public health threats in the World Health
Organization (WHO) European Region. Viral hepatitis surveillance shortcomings
have resulted in many WHO Member States having insufficient data available to
guide decision-making. This study describes surveillance in the region based on
a quantitative sub-analysis of findings from the 2013 WHO viral hepatitis policy
report and a ...
Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces
Tập 1 - Trang 1-8 - 2016
Hepatitis C virus (HCV) imposes a considerable disease burden in China, with at
least 10 million people chronically infected. Little is known about the
financial impact of the HCV epidemic, nor about the extent to which various
forms of insurance are providing HCV patients with financial protection. A
cross-sectional multi-site study was conducted to acquire data that will aid
policy-makers and ot...